Pulse Biosciences (PLSE) Current Assets (2015 - 2026)

Pulse Biosciences has reported Current Assets for 12 years, with the latest figure at $105.7 million in Q2 2026.

• On a quarterly basis, Current Assets fell 2.27% year-over-year to $105.7 million in Q2 2026; TTM through Jun 2026 was $105.7 million, a 2.27% decrease from a year earlier, with the FY2025 full-year figure at $83.4 million, down 30.16% from the prior year.
• Current Assets was $105.7 million for Q2 2026 at Pulse Biosciences, up from $83.4 million in the prior quarter.
• The five-year high for Current Assets was $120.9 million in Q1 2025, with the low at $22.2 million in Q1 2022.
• Average Current Assets over 5 years is $68.8 million, with a median of $62.1 million recorded in 2022.
• The sharpest annual moves came in 2022 and 2025: Current Assets plunged 64.24% in 2022, then soared 297.08% in 2025.
• Over 5 years, Current Assets stood at $62.1 million in 2022, then decreased by 27.06% to $45.3 million in 2023, then jumped by 163.52% to $119.4 million in 2024, then tumbled by 30.16% to $83.4 million in 2025, then advanced by 26.71% to $105.7 million in 2026.
• The last three Current Assets figures came in at $105.7 million (Q2 2026), $83.4 million (Q4 2025), and $97.2 million (Q3 2025), per Business Quant data.